XML 120 R92.htm IDEA: XBRL DOCUMENT v3.23.3

Goodwill and Other Intangible Assets - Intangible Assets Impairment (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Asset Impairment Charges [Abstract]
Impairment of intangible assets, finite-lived		$ 4.9
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income		Impairment expense
Neos Therapeutics, Inc.
Asset Impairment Charges [Abstract]
Impairment of intangible assets, finite-lived	$ 2.6
Consumer Health Segment
Asset Impairment Charges [Abstract]
Impairment of intangible assets, finite-lived		$ 2.2
Consumer Health Segment | Innovus Pharmaceuticals, Inc
Asset Impairment Charges [Abstract]
Impairment of intangible assets, finite-lived	$ 3.0
Trade Names
Asset Impairment Charges [Abstract]
Impairment of intangible assets, finite-lived		0.2
AcipHex
Asset Impairment Charges [Abstract]
Impairment of intangible assets, finite-lived		2.6
ZolpiMist
Asset Impairment Charges [Abstract]
Impairment of intangible assets, finite-lived		1.4
Tussionex
Asset Impairment Charges [Abstract]
Impairment of intangible assets, finite-lived		0.5
Cefaclor
Asset Impairment Charges [Abstract]
Impairment of intangible assets, finite-lived		$ 0.2

X

- References

No definition available.

+ Details

Name:	us-gaap_AssetImpairmentChargesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Indicates line item in statement of income or comprehensive income that includes impairment of finite-lived intangible asset.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482665/350-30-50-3

+ Details

Name:	us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
Namespace Prefix:	us-gaap_
Data Type:	enum2:enumerationSetItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482665/350-30-50-3

+ Details

Name:	us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_NeosTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=aytu_ConsumerHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=aytu_AciphexMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=aytu_ZolpiMistMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=aytu_TussionexMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=aytu_CefaclorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: